MIM
Monashee Investment Management’s Cidara Therapeutics CDTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-369,099
| Closed | -$3.97M | – | 45 |
|
2024
Q3 | $3.97M | Hold |
369,099
| – | – | 0.43% | 29 |
|
2024
Q2 | $4.41M | Hold |
369,099
| – | – | 0.57% | 21 |
|
2024
Q1 | $340K | Hold |
369,099
| – | – | 0.04% | 102 |
|
2023
Q4 | $293K | Hold |
369,099
| – | – | 0.05% | 41 |
|
2023
Q3 | $348K | Hold |
369,099
| – | – | 0.15% | 71 |
|
2023
Q2 | $417K | Hold |
369,099
| – | – | 0.1% | 65 |
|
2023
Q1 | $469K | Buy |
+369,099
| New | +$469K | 0.13% | 51 |
|
2022
Q4 | – | Sell |
-369,099
| Closed | -$232K | – | 47 |
|
2022
Q3 | $232K | Buy |
+369,099
| New | +$232K | 0.09% | 50 |
|
2022
Q2 | – | Sell |
-369,099
| Closed | -$307K | – | 31 |
|
2022
Q1 | $307K | Buy |
+369,099
| New | +$307K | 0.09% | 34 |
|
2021
Q4 | – | Sell |
-369,099
| Closed | -$827K | – | 63 |
|
2021
Q3 | $827K | Buy |
+369,099
| New | +$827K | 0.15% | 123 |
|
2021
Q2 | – | Sell |
-369,099
| Closed | -$982K | – | 436 |
|
2021
Q1 | $982K | Hold |
369,099
| – | – | 0.15% | 183 |
|
2020
Q4 | $738K | Hold |
369,099
| – | – | 0.1% | 174 |
|
2020
Q3 | $1.05M | Hold |
369,099
| – | – | 0.23% | 90 |
|
2020
Q2 | $1.36M | Hold |
369,099
| – | – | 0.2% | 119 |
|
2020
Q1 | $915K | Hold |
369,099
| – | – | 0.49% | 18 |
|
2019
Q4 | $1.42M | Hold |
369,099
| – | – | 1.32% | 28 |
|
2019
Q3 | $738K | Sell |
369,099
-111,752
| -23% | -$223K | 0.34% | 70 |
|
2019
Q2 | $808K | Hold |
480,851
| – | – | 0.21% | 92 |
|
2019
Q1 | $1.27M | Hold |
480,851
| – | – | 0.29% | 85 |
|
2018
Q4 | $1.13M | Buy |
+480,851
| New | +$1.13M | 0.77% | 38 |
|
2018
Q3 | – | Hold |
0
| – | – | – | 57 |
|
2018
Q2 | – | Hold |
0
| – | – | – | 67 |
|